2026 Vol.16 No.52026 Vol.16 No.42026 Vol.16 No.32026 Vol.16 No.22026 Vol.16 No.12025 Vol.15 No.62025 Vol.15 No.52025 Vol.15 No.42025 Vol.15 No.32025 Vol.15 No.22025 Vol.15 No.1 Free Access2024 Vol.14 No.62024 Vol.14 No.52024 Vol.14 No.42024 Vol.14 No.32024 Vol.14 No.22024 Vol.14 No.12023 Vol.13 No.3/42023 Vol.13 No.22023 Vol.13 No.12022 Vol.12 No.42022 Vol.12 No.32022 Vol.12 No.22022 Vol.12 No.12021 Vol.11 No.42021 Vol.11 No.32021 Vol.11 No.22021 Vol.11 No.12020 Vol.10 No.42020 Vol.10 No.32020 Vol.10 No.22020 Vol.10 No.12019 Vol.9 No.3/42019 Vol.9 No.22016 Vol.9 No.12015 Vol.8 No.3/42015 Vol.8 No.1/22014 Vol.7 No.3/42014 Vol.7 No.1/22013 Vol.6 No.42013 Vol.6 No.32013 Vol.6 No.1/22012 Vol.5 No.3/42012 Vol.5 No.22012 Vol.5 No.12011 Vol.4 No.42011 Vol.4 No.32010 Vol.4 No.1/22009 Vol.3 No.42009 Vol.3 No.32009 Vol.3 No.22009 Vol.3 No.12008 Vol.2 No.42008 Vol.2 No.32008 Vol.2 No.22008 Vol.2 No.12007 Vol.1 No.42007 Vol.1 No.32006 Vol.1 No.1/2

International Journal of Intellectual Property Management (IJIPM)

International Journal of Intellectual Property Management

2006 Vol.1 No.1/2

Special Issue on TRIPS and Beyond: Pharmaceutical Patents and Test Data Protection

Guest Editor: Professor Carlos Correa

Foreword

Pages Title and author(s)
4-21Pharmaceutical inventions: when is the granting of a patent justified?
Carlos M. Correa
DOI: 10.1504/IJIPM.2006.011019
22-36Compulsory licences: recent experiences in developing countries
Cecilia Oh
DOI: 10.1504/IJIPM.2006.011020
37-53Tripping up TRIPS debates IP and health in bilateral agreements
Jean-Frederic Morin
DOI: 10.1504/IJIPM.2006.011021
54-74Intervention of health authorities in patent examination: the Brazilian practice of the prior consent
Maristela Basso
DOI: 10.1504/IJIPM.2006.011022
75-93The impact of FTAs on public health policies and TRIPS flexibilities
Pedro Roffe, Christoph Spennemann
DOI: 10.1504/IJIPM.2006.011023
94-112Pledges and pitfalls: Canada's legislation on compulsory licensing of pharmaceuticals for export
Richard Elliott
DOI: 10.1504/IJIPM.2006.011024
113-130Public health-friendly options for protecting pharmaceutical registration data
Robert Weissman
DOI: 10.1504/IJIPM.2006.011025
131-149The new Indian patent law: a challenge for India
Santanu Mukherjee
DOI: 10.1504/IJIPM.2006.011026
150-172Free trade agreements and TRIPS-plus measures
Francisco Rossi
DOI: 10.1504/IJIPM.2006.011027

 

Return to top